BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 5.69 BATS BZX Real-Time Price As of 2:47pm ET |  +0.025 / +0.44%Today’s Change | 4.83 Today|||52-Week Range 12.08 | -50.44% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Stonehouse Jon P President & Chief Executive Officer |  Sale | 12/15/2022 | 14,100 | $10.90 | $153.7K | -47.55% |
Hutson Nancy J Director | Sale | 6/14/2023 | 12,866 | $8.04 | $103.4K | -28.59% |
Stonehouse Jon P President & Chief Executive Officer |  Buy | 3/21/2023 | 31,055 | $3.22 | $100.0K | -30.60% |
Gayer Charles K Chief Commercial Officer | Sale | 12/15/2022 | 6,100 | $10.90 | $66.5K | -47.55% |
Doyle Anthony /biocryst/ Chief Financial Officer | Sale | 12/15/2022 | 5,700 | $10.90 | $62.1K | -47.55% |
Thackray Helen M Chief Research & Development Officer | Sale | 4/03/2023 | 7,000 | $8.29 | $58.0K | -32.26% |
Barnes Alane P Chief Legal Officer | Sale | 12/15/2022 | 4,175 | $10.88 | $45.4K | -47.55% |
Thackray Helen M Chief Research & Development Officer | Sale | 12/15/2022 | 3,125 | $10.89 | $34.0K | -47.55% |
Sanders A Machelle Director | Sale | 6/15/2023 | 4,000 | $7.98 | $31.9K | -28.95% |
Lee Kenneth B Jr Director | Buy | 1/31/2023 | 15,000 | $1.71 | $25.7K | -46.26% |
Page of 4